Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Wegovy is a GLP-1 agonist containing semaglutide ... While Rybelsus is not a weight loss medication, the same study saw participants weighing over 200 pounds lose an average of 5 to 8 pounds.